360° SearchNetwork Hot Spots Trends Time Series

L-Dopa

Type: Keyphrase

Name: L-Dopa

First reported 16 hours ago - Updated 16 hours ago - 1 reports

Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation

Deep brain stimulation of the subthalamic nucleus (DBS‐STN) is thought to continuously alter the activity of STN neurons in Parkinson's disease (PD). A chronic decrease in the levodopa dose with continuous STN stimulation may induce plastic neuronal ... [Published Bionity.com - 16 hours ago]

Entities: Catecholamine, Dihydroxyphenylalanine, Deep Brain Stimulation, Metabolite

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Chasing the cure for Parkinson’s disease

Research for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptomsI recently watched a great local artist at work, focused on hanging his commissioned piece of art. ... [Published PMLive - May 21 2013]

Entities: L-Dopa, Dopamine, agonist, Patient, Parkinson's Disease

First reported May 17 2013 - Updated May 17 2013 - 1 reports

The Parkinson's Puzzle

Piecing Together the Parkinson's PuzzleResearchers are making strides in understanding the disease, its causes, and treatment. Here's a look at some of the latest scientific findings.More than a million Americans have the neurological disorder Parkinson’s ... [Published EverydayHealth.com - May 17 2013]

Entities: Protein, Nicotine, mitochondria, Dopamine, Patient

First reported May 15 2013 - Updated May 15 2013 - 1 reports

U.S. WorldMeds launches Parkinson's related drug trial

Louisville-based pharmaceuticals firm U.S. WorldMeds has launched a clinical trial investigating a drug called Apokyn as a treatment for morning akinesia in Parkinson’s disease patients.Patients with morning akinesia can experience hand tremors, muscle ... [Published Business First of Louisville - May 15 2013]

Entities: Akinesia, Drugs, L-Dopa

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Deep brain stimulation: a fix when the drugs don't work

Symptoms of these disorders differ extensively – from motor dysfunction in Parkinson’s disease, memory loss in Alzheimer’s disease to inescapable cravings in drug addiction.Drug treatments are often ineffective in these disorders. But what if there was ... [Published Electronics News Australia - May 14 2013]

Entities: Deep Brain Stimulation, Electrode, Dopamine, Parkinson's Disease

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Patent Issued for R(-)-2-Methoxy-11-Hydroxyaporphine and Der. . .

Patent Issued for R(-)-2-Methoxy-11-Hydroxyaporphine and DerivativesThe McLean Hospital CorporationNewsRx.comBy a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Neumeyer, ... [Published Equities.com - May 08 2013]

Entities: Dopamine, Carbon, Heterocyclic Compound, Parkinson's Disease, L-Dopa

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease

NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's."The current therapeutic options for PD ... [Published News-Medical.Net - May 07 2013]

Entities: Therapeutics, Parkinson's Disease, Harry Tracy, Newron Pharmaceuticals SpA, Dyskinesia

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Parkinson’s disease

is Professor of Geriatric Neurology at Monash University, Melbourne. He is the Director of the Victorian Comprehensive Parkinson Program at Kingston Centre Southern Health and Elsternwick Private Hospital, and also directs the Geriatric Research Unit ... [Published Medical Observer - May 06 2013]

Entities: The Parkinsons, Dopamine, L-Dopa

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Brain Research and the Search for Parkinson’s Cure

April is Parkinson’s Awareness Month and AARP is happy to have The Michael J. Fox Foundation for Parkinson’s Research (MJFF) as a guest blog contributor. Throughout the month of April MJFF is sharing insight into the Parkinson’s research landscape, advice ... [Published AARP Bulletin Today - May 01 2013]

Entities: Biomarker, Drugs, treatments

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Healthy Memphis: Slow progression of Parkinson's gives time to plan for future

What you should knowPeople often describe very old people by the way they move. Adjectives like “stiff,” “slow,” “unsteady” and “shaking” are used repeatedly. In some cases, the elderly may have symptoms of Parkinson’s disease (PD).PD is a very individual ... [Published Memphis Commercial Appeal - Apr 29 2013]

Entities: Patient, L-Dopa, Memphis (Tennessee, United States), Drugs

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Civitas Therapeutics Announces Positive Phase 2 Clinical Results [Professional Services Close - Up]

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced positive topline results from a Phase 2 clinical trial of CVT-301, an inhaled formulation ... [Published Pharmacy Choice - Apr 29 2013]

Entities: L-Dopa, Parkinson's Disease, Therapeutics, Dihydroxyphenylalanine

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar(R) / Prolopa(R)

By definition, a generic product is considered interchangeable with the innovator brand product. Controversy exists about interchangeability, and attention is predominantly directed to contaminants. In particular for chronic, degenerative conditions such ... [Published BMC - Apr 23 2013]

Entities: L-Dopa, Roche Holding AG, Degradation, PDF, Dissolution

Quotes

The paper stated that "clinically relevant differences emerged between the 2 groups that persisted beyond the 12-month exposure to the study drug, which may potentially reflect biological activity."

Byetta may ease Parkinson's, study says [Published U-T San Diego - May 20 2013]

...c New study "Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018" by Transparency Market Research is available at MarketPublishers...

New clinical trial investigates APOKYN for treating debilitating morning akinesia in Parkinson's ... [Published NewsBlaze - May 13 2013]

...for people with Parkinson s disease who suffer from morning akinesia and gastroparesis," said P Breckinridge "Breck" Jones, CEO of US WorldMeds. "APOKYN, which has offered great benefit to patients experiencing OFF episodes, has shown initial promise in helping to alleviate symptoms associated with these conditions. US WorldMeds is committed to working with researchers and healthcare providers to advance the application and delivery of this medication."

New clinical trial investigates APOKYN for treating debilitating morning akinesia in Parkinson’s ... [Published Business Wire - May 13 2013]

"The invention features a method for treating Parkinson's disease, sexual dysfunction, or depressive disorders in a patient, e g., a human patient, by administering an effective amount of a compound of the invention. These compounds are particularly useful for treating depressive disorders, such as major depression, dysthymia, bipolar disorder (manic depression), and post traumatic stress disorder."

Patent Issued for R(-)-2-Methoxy-11-Hydroxyaporphine and Der. . . [Published Equities.com - May 08 2013]

More Content

sort by: Date \| Relevance
Urinary profile of catecholamines and metabolit... [Published Bionity.com - 16 hours ago]
Energy Supplement Category Expands to Include A... [Published PRWeb - May 22 2013]
Chasing the cure for Parkinson’s disease [Published PMLive - May 21 2013]
Byetta may ease Parkinson's, study says [Published U-T San Diego - May 20 2013]
The Parkinson's Puzzle [Published EverydayHealth.com - May 17 2013]
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): T... [Published InsiderMonkey.com - May 15 2013]
U.S. WorldMeds launches Parkinson's related dru... [Published Business First of Louisville - May 15 2013]
2 Scariest Dividend Stocks in Health Care [Published Motley Fool - May 15 2013]
Deep brain stimulation: a fix when the drugs do... [Published Electronics News Australia - May 14 2013]
New clinical trial investigates APOKYN for trea... [Published NewsBlaze - May 13 2013]
New clinical trial investigates APOKYN for trea... [Published Business Wire - May 13 2013]
Avanir Pharmaceuticals' CEO Discusses F2Q13 Res... [Published Seeking Alpha - May 09 2013]
Redefining Parkinson’s research: Study takes st... [Published MolecularImaging.net - May 08 2013]
Patent Issued for R(-)-2-Methoxy-11-Hydroxyapor... [Published Equities.com - May 08 2013]
ZN, GLUU, XNPT, TRS, TITN, HEK Are Seasonally R... [Published TradingCharts.com - May 07 2013]
Neuroperspective reviews status and prospects o... [Published News-Medical.Net - May 07 2013]
Parkinson’s disease [Published Medical Observer - May 06 2013]
Parkinson's Therapeutics Reviewed by NeuroPersp... [Published NewsBlaze - May 06 2013]
Parkinsons Therapeutics Reviewed by NeuroPerspe... [Published Street Insider - May 06 2013]
Parkinson's Therapeutics Reviewed by NeuroPersp... [Published TickerTech.com - May 06 2013]
New Parkinson's Disease Findings Has Been Repor... [Published Pharmacy Choice - May 06 2013]
Rare courses in offing for medics [Published Calcutta Telegraph - May 06 2013]
Midlander on mission to find cure for degenerat... [Published My West Texas - May 06 2013]
Newron reports encouraging results from Phase I... [Published Zecco - May 03 2013]
Brain Research and the Search for Parkinson’s Cure [Published AARP Bulletin Today - May 01 2013]
Addex Reports that Dipragluant Demonstrated Dos... [Published Interest!ALERT - May 01 2013]
Addex Reports that Dipragluant Demonstrated Dos... [Published Presscontacts.com - May 01 2013]
Addex Therapeutics : Addex Reports that Dipragl... [Published Investegate - May 01 2013]
Addex Reports that Dipragluant Demonstrated Dos... [Published Yahoo! Finance - May 01 2013]
ADDEX PHARMACEUTICALS SA: Reports that Dipraglu... [Published 4 Traders - May 01 2013]

Blogs

sort by: Date \| Relevance
Raising Dopamine In Old Brains Improves Decisio... [Published FuturePundit - Mar 25 2013] L-Dopa, a drug used to boost dopamine in brains of Parkinson's patients, boosts brain performance of people in their 70s. A drug widely used to treat Parkinson's Disease can help to reverse age-related impairments in decision making in some older people, ...
Deals of the Week Wants Cash on the Barrelhead [Published The IN VIVO Blog - Mar 22 2013] For pharmas making all but the largest acquisitions, cash is king. From speculative buyouts of preclinical start-ups all the way through bolt-on deals worth a few billion dollars, pharmas typically spend cash rather than swap stock to make their acquisitions. ...
4 Healthcare Stock Stories Prescribed for Inves... [Published Wall St. Cheat Sheet - Mar 20 2013] Biogen IDEC ( NASDAQ:BIIB ): Current price $177.31 On Wednesday, Biogen announced the positive, full first-year results from its two-year pivotal Phase 3 ADVANCE study of Plegridy (peginterferon beta-1a), its investigational candidate for relapsing-remitting ...
Breaking down the Parkinson’s pathway [Published MIT News feed - Mar 12 2013] The key hallmark of Parkinson’s disease is a slowdown of movement caused by a cutoff in the supply of dopamine to the brain region responsible for coordinating movement. While scientists have understood this general process for many years, the exact details ...
Breaking News: I Love Yet Another Laura Stevens... [Published The Stranger, Seattle's Only Newspaper - Mar 04 2013] Well, I continue to love every fucking thing Laura Stevenson does. SHOCKING, I KNOW. Today she released another new single, "L-DOPA," from her upcoming album, Wheel (out on Don Giovanni April 23), and now I'll spend the rest of the day listening to ...

Audio/Video

sort by: Date \| Relevance
Parkinson's drug linked to artistic spark [Published Reuters Video: Technology - Feb 11 2013]

Press Releases

sort by: Date \| Relevance
New clinical trial investigates APOKYN for trea... [Published Business Wire - May 13 2013]
Civitas Therapeutics Announces Positive Phase 2... [Published Business Wire - Apr 19 2013]
Civitas Therapeutics Announces Positive Phase 2... [Published Business Wire Health News - Apr 19 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published PR Newswire: Health - Apr 15 2013]
Biotie Presents Tozadenant Phase 2b Data at AAN... [Published Marketwire - Breaking News Releases - Mar 21 2013]